000			01636 a2200433 4500
005			20250517095832.0
264		0	_c20170713
008			201707s 0 0 eng d
022			_a1476-5454
024	7		_a10.1038/eye.2016.96 _2doi
040			_aNLM _beng _cNLM
100	1		_aMoon, J
245	0	0	_aCombination therapy of intravitreal bevacizumab with single simultaneous posterior subtenon triamcinolone acetonide for macular edema due to branch retinal vein occlusion. _h[electronic resource]
260			_bEye (London, England) _cAug 2016
300			_a1084-90 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial
650	0	4	_aAged
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aBevacizumab _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGlucocorticoids _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIntravitreal Injections
650	0	4	_aMacular Edema _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aRetinal Vein Occlusion _xcomplications
650	0	4	_aTenon Capsule _xdrug effects
650	0	4	_aTomography, Optical Coherence
650	0	4	_aTriamcinolone Acetonide _xtherapeutic use
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVisual Acuity _xphysiology
700	1		_aKim, M
700	1		_aSagong, M
773	0		_tEye (London, England) _gvol. 30 _gno. 8 _gp. 1084-90
856	4	0	_uhttps://doi.org/10.1038/eye.2016.96 _zAvailable from publisher's website
999			_c26063169 _d26063169